{
    "url_original": "https://www.wsj.com/articles/u-s-purchases-10-million-treatment-courses-of-pfizers-covid-19-pill-11637247263?mod=politics_lead_pos13",
    "url": "u-s-purchases-10-million-treatment-courses-of-pfizers-covid-19-pill-11637247263",
    "title": "U.S. Buys 10 Million Treatment Courses of Pfizer’s Covid-19 Pill for $5.29 Billion",
    "sub_head": "The FDA is reviewing the antiviral drug and could decide whether to approve it by the end of this year",
    "category_1": "Business",
    "category_2": "Health Care",
    "time": "2021-11-18 10:47:00",
    "body": "Pfizer Inc.  said Thursday it agreed to a $5.29 billion deal with the U.S. to provide enough supplies of its promising Covid-19 pill to treat 10 million people, should health regulators give it the green light.<br />The company’s antiviral drug, Paxlovid, is under review by the U.S. Food and Drug Administration, and a decision could come before the end of the year."
}